About Us
At BRENTEC, the mission is to advance livelihoods by enhancing animal health. As a start-up company, planning is done decades ahead. The use of science to improve livelihoods forms the basis of our operations. The inquiry into how science can create advanced and improved livelihoods for farmers in Africa is addressed through innovation and compassion, utilizing cutting-edge technologies and strong connections to communities to develop advancements in animal health vaccines. Collaboration is conducted globally and with integrity. This focus defines our identity, purpose, methodology, and objectives.
What We Do
BRENTEC is engaged in the discovery, development, manufacturing, and commercialization of vaccines and other technologies for livestock.
Why We Do What We Do
Animal health is important to public health and people’s well-being. Our goal is to provide advance care and health solutions for animals to enhance the livelihoods of the communities we serve.
How We Do What We Do
Our vision is to become the most trusted and valued company in the field of animal health, leading the future of animal care through our innovation, dedication to customers, and purpose-driven team members. Our future performance will be guided by these strategic priorities:
Innovation: We lead through innovation to develop products that are uniquely suited for the African farmer and eliminate their accessibility to animal health solutions for their livestock
Affordability: Price is paramount in the consumers´ decision making paradigm when choosing what vaccine to use. At BRENTEC we are committed to helping consumers manage their livestock needs while also managing their costs. To help us meet our commitment, we invest in robust quality systems that enable us to manufacture high-quality products while keeping our production costs low.
Sustainability: Our production system seeks continuous enhancements across the entire supply chain, including formulation, packaging, design, and efficacy of the vaccines we produce, to address market demands identified by our customers. We are committed to minimising waste, improving energy efficiency, and implementing green technologies to reduce environmental impact.
At A Glance
BRENTEC’s vaccine operations started in 2011 with the completion of the construction of a pilot scale manufacturing facilty ate the Uganda Industrial Research Institute Nakawa Campus.
We are proud to have launched KUKUSTAR®; a thermostable vaccine against Newcastle Disease during the 2014 fiscal year. This vaccine has been formulated specifically for use in the tropical climate zones of sub-Saharan Africa. KUKUSTAR® is the only locally manufactured thermostable vaccine in the region that is registered for use. Our customers include pharmacies, agro veterinary input supply shops, hatcheries, commercial farmers and small holder farmers.
We arededicated to developing the livestock
sector in Africa. The Livestock industry is key to economic development in all African
countries and is a major poverty alleviation tool used to uplift the livelihoods of poor rural
households. BRENTEC’s aim is to provide access to quality and affordable first line
vaccinations to support this sector and thus eliminate the major diseases that are a
hindrance to the development of this sector of the economy.
Our Team
The management team at BRENTEC is committed to steering the company’s vision and strategic direction with utmost integrity, legality, and responsibility. Our goal is to foster growth and fulfill our commitments to farmers in Africa.
Paul Rubayiza COMPANY PHARMACIST
Herbert Ssemwanga
PRODUCTION MANAGER
George Mukiibi
HEAD R&D
Peter Mayombwe MARKETING SUPERVISOR
Ntale Bridget
QUALITY CONTROL SUPERVISOR
Judith Chemos ACCOUNTANT
Namawa Godfrey PRODUCTION OFFICER
Board of Directors
Our Board comes from a diverse background in both life sciences and finance. They guide our operations to ensure the BRENTEC remains true to its intended goals
Awards & Recognition
2015 - 2nd largest development impaCT
2011- TOP 50 SME AWARD
